GILD vs INHD · P/E 18, rev $7.80B vs rev $2.8M
Gilead Sciences Inc (GILD) versus Inno Holdings Inc. Common Stock (INHD) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Inno Holdings Inc. Common Stock (INHD) is a steel company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported INHD revenue for 2025-09-30 was $2.8M. Net income was -$7.1M. Revenue was up 221.4% from 2024-09-30 to 2025-09-30. INHD currently screens at market cap $4.7M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. INHD currently screens at market cap $4.7M.
Not investment advice. Open the GILD and INHD stock pages for the full models.
Not investment advice.